There was no difference in NKG2A expression levels in PBMCs in the CRC patients and in the healthy controls [mean ± SD, 1.02±0.47 (CRC patients) vs. 1.25±0.52 (healthy controls)]; p>0.05] (Fig. 1B). This evidence concerns the gene KLRC1 and colorectal carcinoma.